I’m wondering if anyone has any thoughts on some profit taking in AAPL at this time. I’m thinking about taking 33% off the table, as I have reached my long term capital gains period with this portion of my investment. The stock is obviously red hot lately, though, and I’ve always heard to never sell […]
Author Archives
Recent Author Comments
Electric semi trucks will further drive nickel and cobalt demand higher https://www.bloomberg.com/amp/news/articles/2017-11-17/tesla-truck-supercharges-hopes-for-boom-in-battery-metals-demand long $CTEQF[...]
Keep dissing the gummie community and the money will dry up. Talking down to people and calling us pathetic just because two people suggest that maybe we should go a little easy on the kool-aid is a sure way to kill a great thread. I know I'm getting fed[...]
MY TOP 10 BIOTECH HOLDINGS NO ORDER: ESPR AKAO AUPH AKBA RDUS BLUE CLVS PTLA SGEN AAVXF[...]
$FGRRF I've been noticing Fingerprint cards AB coming up a lot, and I have not followed too closely. Maybe this has already come up, but last I heard they were struggling https://www.bloomberg.com/news/articles/2017-03-21/fingerprint-cards-withdraws-divide[...]
$AKAO - Anyone know what the hell this Form D is from Akaogen? Never seen one of these before, looks odd. Long $AKAO[...]
$AKBA on fire lately. Lots of good things going for this company. CAMBRIDGE, Mass. & ZURICH--(BUSINESS WIRE)-- Akebia Therapeutics, Inc. (NASDAQ:AKBA) and Vifor Pharma Group. today announced they have entered into an exclusive license agreement to s[...]
Stick to the important things- biotech discussions... that's what I'm talkin about, LostOkie![...]
Gummies, I beg you, please stop feeling the need to individually respond scoldingly to every negative post that comes up here. You're wasting so much time for many people reading notifications. These people aren't deserving of a response. If you feel the n[...]
Bought into Radius Health ($RDUS) just the other day. I'm having some amazing timing lately. FDA Approves Radius Health's TYMLOS(TM) (abaloparatide), a Bone Building Agent for the Treatment of Postmenopausal Women with Osteoporosis at High Risk for Fract[...]
$AKBA Akebia and Otsuka Expand Relationship with Collaboration to Develop and Commercialize Vadadustat in Europe, China and Other Territories Maximizes Efficiency of Global Development and Commercialization Committed Capital and Potential Milestone Pay[...]
Subscribe link?[...]
long $AUPH :)[...]
$AUPH public offering. First real test http://ir.auriniapharma.com/press-releases/detail/77[...]
Doing some trading today, huh, doc? :) me too ... just entered $AKBA! Long overdue that I own this one, ready for takeoff now :)[...]
SORRY if it's already already been discued but someone explain to me the situation NEw mountain advisors is in with $BLph? ALso, why can't I post normally on this thread? Caps is all jacked up[...]
New buy for me today - Kindred Biosciences $KIN. Not sure if this one has come up here before, but it's another animal health care biotech that looks quite cheap at 2x cash with no debt. Lots in the pipeline. Has seen massive insider buying lately and ha[...]
nice pop today in $ESPR on 10x average volume and no apparent news. Broke through key short term resistance. Filled the gap down from June 2016. Long $ESPR[...]
Bit the bullet and quadrupled my position in $ESPR today. Granted, I sold off most for a nice profit last year, and then the share price hasn't been crushed so my position became quite small. Very much over sold here imo and institutional investors seem to[...]
phew ... I mean, good for you if it had been your biggest holding, but you would have to be nuts to be positioned in that way[...]
We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.
More Info
$CWBR Thanks for the Christmas gift, Doc. Weird (and possibly stupid) question that just kind of came to mind. I doubt it’s been discussed before. Do treatments like MOTS-C alter one’s genetic makeup? Is there any chance treatments like these and gene [...]